GREGORY A GOULD Insider Trading
Get free email notifications about insider trading for GREGORY A GOULD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREGORY A GOULD. GREGORY A GOULD is a Chief Financial Officer in ATRIX LABORATORIES INC ($ATRX) and a Director in CytoDyn Inc. ($CYDY) and a Chief Financial Officer in AYTU BIOSCIENCE, INC ($RSWN) and a Chief Financial Officer in Ampio Pharmaceuticals, Inc. ($AMPE) and a CFO in New Age Beverages Corp ($NBEV) and a Chief Financial Officer in New Age Beverages Corp ($NBEV).
Address: C/O FAEGRE & BENSON LLP 1900 FIFTEENTH STREET BOULDER 80302 CO
Companies in which GREGORY A GOULD is an Insider
Ampio Pharmaceuticals, Inc.
Trading Symbol: AMPEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY A GOULD: Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 19 2016
$AMPE Market Capitalization: $54.49M
$AMPE Previous Close: $1.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ATRIX LABORATORIES INC
Trading Symbol: ATRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY A GOULD: Chief Financial Officer
Holdings: 0 shares
Latest Transaction: May 10 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AYTU BIOPHARMA, INC
Trading Symbol: AYTUIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY A GOULD: Chief Financial Officer
Holdings: 340,231 shares
Current Value: $302,806
Latest Transaction: Mar 17 2017
$AYTU Market Capitalization: $11.06M
$AYTU Previous Close: $0.89
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CytoDyn Inc.
Trading Symbol: CYDYIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY A GOULD: Director
Holdings: 19,176 shares
Current Value: $13,807
Latest Transaction: Jun 19 2019
$CYDY Market Capitalization: $103.82M
$CYDY Previous Close: $0.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NewAge, Inc.
Trading Symbol: NBEVIndustry: MALT BEVERAGES [2082]
Position of GREGORY A GOULD: Chief Financial Officer, CFO
Holdings: 404,365 shares
Latest Transaction: Mar 12 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of GREGORY A GOULD
Sentiment: All, AMPE, ATRX, AYTU, CYDY, NBEV
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 12 2021 | NBEV | NewAge, Inc. | Gould Gregory A | Chief Financial Off ... | Option Exercise | A | 2.79 | 125,000 | 348,750 | 125,000 | |
Jan 05 2021 | NBEV | NewAge, Inc. | Gould Gregory A | Chief Financial Off ... | Payment of Exercise | F | 2.63 | 26,507 | 69,713 | 404,365 | 430.9 K to 404.4 K (-6.15 %) |
Dec 11 2020 | NBEV | NewAge, Inc. | Gould Gregory A | Chief Financial Off ... | Payment of Exercise | F | 3.16 | 9,564 | 30,222 | 430,872 | 440.4 K to 430.9 K (-2.17 %) |
Oct 26 2020 | NBEV | NewAge, Inc. | Gould Gregory A | Chief Financial Off ... | Payment of Exercise | F | 2.72 | 9,564 | 26,014 | 440,436 | 450 K to 440.4 K (-2.13 %) |
Dec 12 2019 | NBEV | New Age Beverages ... | Gould Gregory A | Chief Financial Off ... | Option Exercise | A | 1.83 | 100,000 | 183,000 | 100,000 | |
Dec 12 2019 | NBEV | New Age Beverages ... | Gould Gregory A | Chief Financial Off ... | Grant | A | 0.00 | 100,000 | 0 | 450,000 | 350 K to 450 K (+28.57 %) |
Jul 03 2019 | NBEV | New Age Beverages ... | Gould Gregory A | CFO | Option Exercise | A | 4.75 | 100,000 | 475,000 | 100,000 |